Regula Christie G, Alam Murad, Behshad Ramona, Glashofer Marc, Hanke C William, Harmon Christopher, Johnson Ryan, Kent David, Lee Patrick, Lawrence Naomi
*Vujevich Dermatology Associates, Pittsburgh, Pennsylvania; †Department of Dermatology, Northwestern University, Chicago, Illinois; ‡Department of Dermatology, St. Louis University, St. Louis, Missouri; §The Dermatology Group, West Orange, New Jersey; ‖Laser and Skin Surgery Center of Indiana, Carmel, Indiana; ¶Surgical Dermatology Group, Birmingham, Alabama; #Dermatology and Skin Surgery Center of Princeton, Princeton, New Jersey; **Dermatologic Surgery Specialists, PC, Macon, Georgia; ††Mercer Medical School, Macon, Georgia; ‡‡Department of Dermatology, University of California, Los Angeles, Los Angeles, California; §§Division of Dermatology, Cooper University Hospital, Marlton, New Jersey.
Dermatol Surg. 2017 Jul;43(7):904-910. doi: 10.1097/DSS.0000000000001111.
Mohs surgery is indisputably a highly effective treatment for nonmelanoma skin cancers. In the current health care environment, physicians are challenged to provide high quality, efficacious care in a manner that is mindful of the patient's general health and well-being. We have used a functional assessment to evaluate older patients who present for Mohs surgery.
The purpose of this study is to categorize the functional status, using the Karnofsky Performance Status (KPS) Scale, of patients 75 years and older undergoing Mohs surgery of a nonmelanoma skin cancer and to identify distinguishing characteristics of lower functioning patients.
Patients 75 years and older undergoing Mohs surgery for nonmelanoma skin cancer at 8 separate geographically diverse sites were included. Patient and tumor characteristics were recorded. Physicians scored subjects on the KPS scale and administered a questionnaire to categorize the symptoms and impact of their skin cancer.
A total of 291 subjects completed the study. The average KPS score was 90.1. 93.1% of our subjects had a KPS score of ≥70. Subjects with a KPS score <70 were more likely to be older with larger symptomatic tumors.
The vast majority of patients 75 years and older undergoing Mohs surgery are highly functioning. Lower functioning patients are older with larger symptomatic tumors that negatively impact their lives.
莫氏手术无疑是治疗非黑色素瘤皮肤癌的一种高效疗法。在当前的医疗环境中,医生面临着挑战,需要以兼顾患者总体健康和福祉的方式提供高质量、有效的治疗。我们采用了功能评估来评价接受莫氏手术的老年患者。
本研究的目的是使用卡氏功能状态量表(KPS)对75岁及以上接受非黑色素瘤皮肤癌莫氏手术的患者的功能状态进行分类,并确定功能较低患者的显著特征。
纳入了在8个地理位置不同的地点接受非黑色素瘤皮肤癌莫氏手术的75岁及以上患者。记录患者和肿瘤的特征。医生用KPS量表对受试者进行评分,并发放问卷以对其皮肤癌的症状和影响进行分类。
共有291名受试者完成了研究。KPS平均得分为90.1。93.1%的受试者KPS评分≥70。KPS评分<70的受试者更可能年龄较大,患有较大的有症状肿瘤。
绝大多数接受莫氏手术的75岁及以上患者功能良好。功能较低的患者年龄较大,患有较大的有症状肿瘤,这些肿瘤对他们的生活产生负面影响。